Omega Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 88.79% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
52.8%	Flagship Pioneering, Inc	29,225,579	US$25.1m	0%	5.8%
11%	FMR LLC	6,062,104	US$5.2m	-2.88%	no data
6.34%	HarbourVest Partners, LLC	3,512,110	US$3.0m	0%	1.15%
3.35%	State of Wisconsin Investment Board	1,857,265	US$1.6m	0%	no data
2.39%	Artal Group S.A.	1,323,530	US$1.1m	0%	0.03%
2.01%	The Vanguard Group, Inc.	1,114,731	US$956.4k	0%	no data
1.91%	CHI Advisors LLC	1,055,882	US$905.9k	0%	0.33%
1.33%	Richard Young	739,118	US$634.2k	0%	no data
1.08%	683 Capital Management, LLC	600,000	US$514.8k	0%	0.05%
0.97%	Millennium Management LLC	535,616	US$459.6k	-29%	no data
0.91%	Point72 Asset Management, L.P.	501,521	US$430.3k	0%	no data
0.86%	Renaissance Technologies LLC	474,600	US$407.2k	270%	no data
0.63%	Platinum Investment Management Limited	346,352	US$297.2k	0%	0.01%
0.57%	Michigan Department of Treasury, Bureau of Investments	314,117	US$269.5k	0%	no data
0.49%	BlackRock, Inc.	271,651	US$233.1k	-25.4%	no data
0.42%	Geode Capital Management, LLC	230,833	US$198.1k	-2.53%	no data
0.35%	Roger Sawhney	193,261	US$165.8k	0%	no data
0.32%	U.S. Global Investors, Inc.	175,000	US$150.2k	0%	0.01%
0.21%	Bridgeway Capital Management, LLC	119,000	US$102.1k	0%	no data
0.21%	Mahesh Karande	117,711	US$101.0k	0%	no data
0.17%	State Street Global Advisors, Inc.	94,730	US$81.3k	0%	no data
0.15%	Long Corridor Asset Management Limited	85,000	US$72.9k	0%	0.07%
0.15%	Two Sigma Investments, LP	81,091	US$69.6k	10%	no data
0.12%	Charles Schwab Investment Management, Inc.	65,111	US$55.9k	0%	no data
0.12%	RBF Capital LLC	63,857	US$54.8k	-3.62%	no data